Help us: Donate
Follow us on:
×

Menu

Back

Tag: Advocacy

Dylan Livingston Interview
Dylan Livingston is the founder and president of A4LI – the Alliance for Longevity Initiatives. This newly created organization aims to fill an important niche as a non-profit that would educate American politicians on life extension and promote policy changes beneficial for our cause. How can this be done, especially in the current age of...
EARD2021 Opening
In his introductory speech for our fourth annual Ending Age-Related Diseases conference, Lifespan.io president Keith Comito discusses the epic of Gilgamesh and how it relates to our modern quest of curing the diseases of aging. Script Good morning, and welcome to the fouth annual Ending Age-Related Diseases conference, and I hope you all are healthy...
The Science and Technology of Growing Young
Sergey Young's The Science and Technology of Growing Young (Lifespan.io is on Amazon Smile) is a mix of exciting longevity research and heady optimism. In an easy-to-read 272 pages, the investor gives a whirlwind tour of research on aging and the companies that are trying to turn this science into technology. In good hands Young...
Old Fact Check
I started to like sci-fi movies as a child, and I am still a fan. However the more I learn about science and technology, the harder it is to ignore inconsistencies and fantasy the producers present as facts in order to excite the viewer. One can still try to enjoy the movie by not thinking...
Highlanders enjoy life extension, would you?
A recent survey of adults in the US found that only about one-third would take a life extension pill if one were available [1]. These findings are about the same as those of an Australian survey a decade ago [2], highlighting the need for more effective life extension advocacy.  A plurality opposed To investigate public...
Empty wallet
The time has come for anti-aging research to incorporate behavioral and social science into its agenda, according to Terrie Moffitt, a psychology and neuroscience professor at Duke University [1]. She explains that doing so will help researchers translate fundamental findings into useful therapies and guide us in ensuring that aging therapies benefit as many people...